Related Experiment Video
Updated: Jun 4, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
ACE up the sleeve - are vascular patients medically optimized?
A P Coveney1, G C O'Brien, G J Fulton
1Department of Vascular Surgery, Cork University Hospital, National University of Ireland, Cork, Ireland. acoveney@gmail.com
Insights
Arteriopathic patients often receive antiplatelets and statins, but angiotensin-converting enzyme (ACE) inhibitors and beta-blockers are under-prescribed. Vascular surgeons can improve medical management by enhancing collaboration and taking greater responsibility for patient care.
Area of Science:
- Vascular Surgery
- Cardiovascular Medicine
- Pharmacology
Background:
- Arteriopathic patients require comprehensive medical management.
- Optimal medical therapy is crucial for improving outcomes in patients with arterial disease.
- Patients with vascular conditions are often managed by multiple medical specialties.
Purpose of the Study:
- To assess the current medical management of arteriopathic patients in a vascular surgical service.
- To evaluate the prescription rates of key cardiovascular medications, including antiplatelets, statins, ACE inhibitors, ARBs, and beta-blockers.
- To determine the influence of different medical specialties on medication prescribing patterns.
Main Methods:
- A 6-month prospective study of sequential patients attending a university teaching hospital's vascular surgical service.
- Data collection included patient demographics, arterial disease type, recent medical consultations, and current medications.
- Specific focus on the use of antiplatelets, statins, ACE inhibitors (or ARBs), and beta-blockers.
Main Results:
- 180 arteriopathic patients (mean age 69) were included.
- Nearly all patients (96%) received antiplatelets, predominantly aspirin.
- High statin use (86%), but lower rates for beta-blockers (44%) and ACE inhibitors (51%).
- Suboptimal prescription of ACE inhibitors and beta-blockers was observed irrespective of specialty consultations.
Conclusions:
- While antiplatelet and statin use aligns with evidence, ACE inhibitors and beta-blockers are under-prescribed in this population.
- Vascular surgeons have an opportunity to improve medical care by adhering to guidelines.
- Enhanced collaboration with primary care or increased surgeon responsibility for medical management is recommended.
Objective:
To examine the current medical management of arteriopathic patients attending a vascular surgical service at a university teaching hospital over a 6-month period. The prescribing of antiplatelets, statins, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers and beta-blockers was specifically examined. Vascular patients are often under the care of multiple specialties, and therefore the influence of different medical specialties on the patients' medical management was also examined.
Design:
Between January and June 2009, data were recorded on sequential patients with arterial disease attending the vascular surgical service. Patients' demographics, type of arterial disease, medical consultations within the previous 12 months, and current medications were recorded.
Results:
The study included 180 patients with a mean age of 69 years (39-88 years). All but 4% were taking an antiplatelet or anticoagulant, predominantly aspirin. There were 86% taking a statin, 44% taking a beta-blocker, and 51% taking an ACE inhibitor. Suboptimal prescription of ACE inhibitors and beta-blockers was evident regardless of the type of medical consultations in the previous year. No specialty group differed significantly from vascular surgeons in their prescribing pattern.
Conclusions:
While almost all arteriopaths receive some form of antiplatelet and statin in line with clinical evidence, ACE inhibitors and beta-blockers appear to be under-prescribed in this arteriopathic population. We conclude that opportunity exists for vascular surgeons to embrace recent guidelines and lead the way in both surgical and medical optimization of arteriopathic patients through improving links with primary care physicians or taking greater responsibility themselves for the medical as well as the surgical care of their arteriopathic patients.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Aortic Regurgitation IV: Nursing Management
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
